Interim data from the ongoing EPITOME trial1 showed that 45.7% of stroke survivors with paresis developed post-stroke spasticity within 1 year<1% of stroke survivors receive BoNT-A treatment for ...
PARIS & BOSTON--(BUSINESS WIRE)--WeHealth by Servier, the e-health department of Servier Group, and PathMaker Neurosystems, a pioneering clinical-stage bioelectronic medicine company, announced today ...
Ipsen has announced the presentation of new study data on Dysport (abobotulinumtoxinA) in stroke and other neurological ...
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced findings from a new U.S. healthcare database analysis to assess the current treatment patterns of adults living ...
(RTTNews) - Allergan, an AbbVie (ABBV) company, said that the U.S. Food and Drug Administration approved a supplemental Biologics License Application or sBLA that supports expanded use of BOTOX for ...
Life with severe spasticity from cerebral palsy is far from easy. Spasticity is an abnormal muscle tightness from contraction that is related to damage to the body's neurological system. Spasticity ...
Fakeeh Health | CEO – Fakeeh University Hospital, stated: “This strategic partnership with Verita Neuro reflects our ...
Complete list of Ipsen presentations at TOXINS 2026: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback